AGIOS PHARMACEUTICALS, INC. Deferred Revenue
AGIOS PHARMACEUTICALS, INC. (AGIO) had Deferred Revenue of $41.13 million as of 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-08-02
- 2018-06-30: Deferred Revenue, Current $41.13M.
- 2018-03-31: Deferred Revenue, Current $39.21M.
- 2017-12-31: Deferred Revenue, Current $37.84M.
- 2017-09-30: Deferred Revenue, Current $35.87M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-06-30 | $41.13M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $39.21M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $37.84M 10-Q · filed 2018-08-02 |
| 2017-09-30 | $35.87M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $37.07M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $37.69M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $35.91M 10-K · filed 2018-02-14 |
| 2016-09-30 | $36.41M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $31.47M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $16.52M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $19.66M 10-K · filed 2017-02-16 |
| 2015-09-30 | $22.65M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $22.61M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $6.89M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $35.69M 10-K · filed 2016-02-26 |
| 2014-09-30 | $18.85M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $33.64M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $25.07M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $25.07M 10-K · filed 2015-02-24 |
| 2013-09-30 | $25.07M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $25.07M 10-Q · filed 2013-09-05 |
| 2012-12-31 | $25.07M 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |